Also trades as: HCG.NS (NSE) · $vol 1M
HCG.BO BSE
HealthCare Global Enterprises Limited
1W: -4.6%
1M: -5.0%
3M: +2.4%
YTD: +14.1%
1Y: -2.0%
3Y: +107.9%
5Y: +223.9%
₹666.00 ($6.92)
+0.05 (+0.01%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$3.5B
+9.5% ▲
5Y CAGR: +23.6%
Capital Expenditures
$2.9B
-39.8% ▼
5Y CAGR: +52.5%
Free Cash Flow
$550M
-49.2% ▼
5Y CAGR: -8.4%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$4.1B
+292.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $878M | $449M | $677M | $570M | $269M |
| Depreciation & Amort. | $1.6B | $1.6B | $1.7B | $2.1B | $2.4B |
| Stock-Based Comp. | $31M | $65M | $78M | $65M | -$566M |
| Change in Working Capital | -$105M | -$459M | -$272M | -$765M | -$425M |
| Other Non-Cash Items | -$185M | $826M | $618M | $1.2B | $1.8B |
| Operating Cash Flow | $2.2B | $2.5B | $2.8B | $3.2B | $3.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$712M | -$1.3B | -$1.9B | -$2.1B | -$2.9B |
| Acquisitions (Net) | $380M | $0 | -$450M | -$2.0B | $0 |
| Investment Purchases | -$824M | -$634M | $0 | -$1.2B | -$1.1B |
| Investment Sales | $2.3B | $502M | $251M | $252M | $2.1B |
| Other Investing | $124M | $134M | -$202M | $110M | $155M |
| Investing Cash Flow | $1.2B | -$1.3B | -$2.3B | -$4.9B | -$1.8B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1.5B | -$453M | $933M | $1.4B | $97M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$1.4B | -$956M | -$1.6B | -$1.9B | -$2.2B |
| Financing Cash Flow | -$1.5B | -$1.4B | -$640M | -$424M | $2.4B |
| Net Change in Cash | $1.9B | -$215M | -$52M | -$2.1B | $4.1B |
| Cash End of Period | $1.9B | $1.7B | $1.7B | -$471M | $3.6B |
| Free Cash Flow | $1.5B | $1.2B | $989M | $1.1B | $550M |